Literature DB >> 2114831

Interleukin 2, soluble interleukin 2 receptor, and interferon-gamma in the suction blister fluids from psoriatic skin.

H Takematsu1, H Tagami.   

Abstract

Psoriasis represents inflammatory skin disorders characterized by significant changes in cellular immunity, particularly exhibiting alterations in T lymphocyte-related functions. Early psoriatic lesions have been reported to show an infiltration of activated helper T cells. Elevated levels of interleukin 2 (IL-2), IL-2 receptor (IL-2R), and interferon-gamma (INF-gamma) are associated with an early activation of T cells. To examine local activation of T cells in psoriatic skin, the amounts of activated T cell products, IL-2, secretory form of IL-2R (sIL-2R) and INF-gamma were measured in the fluids of suction blisters raised on psoriatic skin. sIL-2R levels were significantly elevated in the suction blister fluids raised on psoriatic involved skin compared with those on normal and psoriatic uninvolved skin. On the other hand, neither IL-2 or IFN-gamma was detected in the suction blister fluids either from normal, psoriatic uninvolved, or involved skin. However, we could detect IFN-gamma and IL-2 in the psoriatic scale extracts. Although we failed to detect IL-2 and IFN-gamma in the suction blister fluids, the increased levels of sIL-2R in the suction blister fluids from the psoriatic lesional skin indicate local activation of T cells in psoriatic lesional skin.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2114831     DOI: 10.1007/bf00372613

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  33 in total

1.  A new method for recovery of exudates from normal and inflamed human skin.

Authors:  A K Black; M W Greaves; C N Hensby; N A Plummer; R A Eady
Journal:  Clin Exp Dermatol       Date:  1977-09       Impact factor: 3.470

2.  Interleukin-2 receptor levels indicating relapse in multiple sclerosis.

Authors:  K Adachi; T Kumamoto; S Araki
Journal:  Lancet       Date:  1989-03-11       Impact factor: 79.321

3.  Serum interleukin-2 receptor levels in atopic dermatitis.

Authors:  B Wüthrich; H J Joller-Jemelka; P J Grob
Journal:  Dermatologica       Date:  1989

4.  Interleukin-1-like activity in horny layer extracts: decreased activity in scale extracts of psoriasis and sterile pustular dermatoses.

Authors:  H Takematsu; R Suzuki; H Tagami; K Kumagai
Journal:  Dermatologica       Date:  1986

5.  Determination of anaphylatoxin concentrations in suction blisters in patients with psoriasis.

Authors:  K Ohkohchi; H Takematsu; H Tagami
Journal:  J Invest Dermatol       Date:  1986-07       Impact factor: 8.551

6.  Structure-function relationships for the IL 2-receptor system. IV. Analysis of the sequence and ligand-binding properties of soluble Tac protein.

Authors:  R J Robb; R M Kutny
Journal:  J Immunol       Date:  1987-08-01       Impact factor: 5.422

7.  Elevated levels of interleukin 2 receptor in sera of patients with atopic dermatitis and psoriasis.

Authors:  A Kapp; A Piskorski; E Schöpf
Journal:  Br J Dermatol       Date:  1988-12       Impact factor: 9.302

8.  Use of monoclonal antibodies as sensitive and specific probes for biologically active human gamma-interferon.

Authors:  T W Chang; S McKinney; V Liu; P C Kung; J Vilcek; J Le
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

9.  Purification of human interleukin 2 to apparent homogeneity and its molecular heterogeneity.

Authors:  K Welte; C Y Wang; R Mertelsmann; S Venuta; S P Feldman; M A Moore
Journal:  J Exp Med       Date:  1982-08-01       Impact factor: 14.307

10.  The effect of Goeckerman therapy on interferon in serum and suction blister fluid from patients with psoriasis.

Authors:  J K Livden; J R Bjerke; M Degre; R Matre
Journal:  Br J Dermatol       Date:  1986-02       Impact factor: 9.302

View more
  6 in total

Review 1.  Immunological mechanisms involved in psoriasis.

Authors:  C E Griffiths; J J Voorhees
Journal:  Springer Semin Immunopathol       Date:  1992

2.  Soluble interleukin-2 receptors and psoriasis.

Authors:  R Dummer; F G Dunkel
Journal:  Arch Dermatol Res       Date:  1991       Impact factor: 3.017

3.  Quantitation of soluble CD27, a T-cell activation antigen, and soluble interleukin-2 receptor in serum from patients with psoriasis.

Authors:  M A de Rie; F Hamerlinck; R Q Hintzen; J D Bos; R A van Lier
Journal:  Arch Dermatol Res       Date:  1991       Impact factor: 3.017

4.  Interferon-gamma-dependent stimulation of human involucrin gene expression: STAT1 (signal transduction and activators of transcription 1) protein activates involucrin promoter activity.

Authors:  H Takahashi; K Asano; S Nakamura; A Ishida-Yamamoto; H Iizuka
Journal:  Biochem J       Date:  1999-12-15       Impact factor: 3.857

5.  Reappraisal of in situ immunophenotypic analysis of psoriasis skin: interaction of activated HLA-DR+ immunocompetent cells and endothelial cells is a major feature of psoriatic lesions.

Authors:  O J de Boer; C M van der Loos; F Hamerlinck; J D Bos; P K Das
Journal:  Arch Dermatol Res       Date:  1994       Impact factor: 3.017

6.  The interleukin-2 receptor in lesions and serum of bullous pemphigoid.

Authors:  D Zillikens; A Ambach; M Schuessler; R Dummer; A A Hartmann; G Burg
Journal:  Arch Dermatol Res       Date:  1992       Impact factor: 3.017

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.